Growth Metrics

Zymeworks (ZYME) Cash from Investing Activities (2021 - 2026)

Zymeworks recorded quarterly Cash from Investing Activities of $70.0 million in Q1 2026, up 1203.26% quarter-over-quarter from $5.4 million in Q4 2025, and up 474.28% year-over-year from $12.2 million in Q1 2025.

Zymeworks' Cash from Investing Activities history runs 6 years deep, the most recent figure standing at $70.0 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities rose 474.28% year-over-year to $70.0 million; the TTM figure through Mar 2026 stood at $84.4 million (up 44.95% YoY), while the FY2025 annual figure was $26.7 million, down 31.2% from the prior year.
  • Cash from Investing Activities came in at $70.0 million for Q1 2026 at Zymeworks, up from $5.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $72.3 million in Q3 2024 to a low of -$138.2 million in Q1 2023.
  • A 5-year average of -$7.4 million and a median of -$6.2 million in 2024 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities slumped 1088.21% in 2022 and jumped 1129.3% in 2024, its largest moves.
  • Zymeworks' Cash from Investing Activities stood at -$22.1 million in 2022, then jumped by 93.94% to -$1.3 million in 2023, then sank by 364.77% to -$6.2 million in 2024, then soared by 186.39% to $5.4 million in 2025, then surged by 1203.26% to $70.0 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $70.0 million, $5.4 million, and $368000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -2.89 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 638.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -431.90 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -428.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -25.54 Mn
10 Zymeworks 1.84 Bn 1.47 Bn - 69.96 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 69.96 Mn
Mar 31, 2026 69.96 Mn
Dec 31, 2025 5.37 Mn
Dec 31, 2025 5.37 Mn
Sep 30, 2025 368,000.00
Sep 30, 2025 368,000.00
Jun 30, 2025 8.75 Mn
Jun 30, 2025 8.75 Mn
Mar 31, 2025 12.18 Mn
Mar 31, 2025 12.18 Mn
Dec 31, 2024 -6.21 Mn
Dec 31, 2024 -6.21 Mn
Sep 30, 2024 72.26 Mn
Sep 30, 2024 72.26 Mn
Jun 30, 2024 -19.97 Mn
Jun 30, 2024 -19.97 Mn
Mar 31, 2024 -7.32 Mn
Mar 31, 2024 -7.32 Mn
Dec 31, 2023 -1.34 Mn
Dec 31, 2023 -1.34 Mn
Sep 30, 2023 -7.02 Mn
Sep 30, 2023 -7.02 Mn
Jun 30, 2023 -60.67 Mn
Jun 30, 2023 -60.67 Mn
Mar 31, 2023 -138.22 Mn
Mar 31, 2023 -138.22 Mn
Dec 31, 2022 -22.07 Mn
Dec 31, 2022 -22.07 Mn
Sep 30, 2022 -30.43 Mn
Sep 30, 2022 -30.43 Mn
Jun 30, 2022 -21.93 Mn
Jun 30, 2022 -21.93 Mn
Mar 31, 2022 20.57 Mn
Mar 31, 2022 20.57 Mn
Dec 31, 2021 -1.86 Mn
Dec 31, 2021 -1.86 Mn